Company intelligence / Profile preview

Kirk Pharmaceuticals

Miramar, Florida, United States

Ownership: Private
Development stage: Other

Overview

Kirk Pharmaceuticals was a Florida-based developer and manufacturer of over-the-counter (OTC) pharmaceutical products, specializing in private-label store brands. The company operated as a contract manufacturing organization (CMO) and a developer of generic OTC formulations for major retailers. In 2008, Kirk Pharmaceuticals was acquired by Perrigo Company, a leading global provider of OTC health and wellness solutions. The acquisition significantly expanded Perrigo's manufacturing capacity and product portfolio in the store-brand market. Today, its operations are integrated into Perrigo's broader consumer healthcare business.

Therapeutic areas: PulmonologyNeurologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Kirk Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kirk Pharmaceuticals.

Explore the full profile